TELA
Tela Bio Inc
NASDAQ: TELA · HEALTHCARE · MEDICAL DEVICES
$0.87
+1.72% today
Updated 2026-04-30
Market cap
$34.90M
P/E ratio
—
P/S ratio
0.44x
EPS (TTM)
$-0.83
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
WallStSmart proprietary scores
33
out of 100
Grade: F
Strong Sell
Investment rating
7.3
Growth
B+5.8
Quality
C+2.0
Profitability
F6.7
Valuation
B5/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$2.25
+157.20%
12-Month target
—
—
Intrinsic (DCF)
$7.70
Margin of safety
+89.79%
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 18.20% QoQ
+ 89.79% below intrinsic value
Risks
- Thin margins at -48.40%
- Negative free cash flow $-4.96M
- Debt/equity 26.98x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $41.42M | $58.45M | $69.30M | $80.28M | $80.28M |
| Net income | $-44.30M | $-46.66M | $-37.84M | $-38.83M | $-9.04M |
| EPS | — | — | — | — | $-0.83 |
| Free cash flow | $-42.62M | $-41.47M | $-42.58M | $-28.67M | $-4.96M |
| Profit margin | -106.95% | -79.83% | -54.60% | -48.37% | -48.40% |
Peer comparison
Smart narrative
Tela Bio Inc trades at $0.87. Our Smart Value Score of 33/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. TTM revenue stands at $80.28M. with profit margins at -48.40%. Our DCF model estimates intrinsic value at $7.70.
Frequently asked questions
What is Tela Bio Inc's stock price?
Tela Bio Inc (TELA) trades at $0.87.
Is Tela Bio Inc overvalued?
Smart Value Score 33/100 (Grade F, Strong Sell). DCF value $7.70.
What is the price target of Tela Bio Inc (TELA)?
The analyst target price is $2.25, representing +157.2% upside from the current price of $0.87.
What is the intrinsic value of Tela Bio Inc (TELA)?
Based on our DCF model, intrinsic value is $7.70, a +89.8% margin of safety versus $0.87.
What is Tela Bio Inc's revenue?
TTM revenue is $80.28M.
Piotroski F-Score?
5/9 — moderate financial health.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.44x
ROE-223.30%
Beta0.99
50D MA$0.73
200D MA$1.22
Shares out0.04B
Float0.02B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—